v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2026
Mar. 31, 2026
Jun. 30, 2025
Mar. 31, 2025
Jun. 30, 2026
Jun. 30, 2025
Dec. 31, 2025
Cash flows from operating activities              
Net loss $ (4,421,840) $ (5,609,874) $ (5,048,167) $ (2,089,208) $ (10,031,714) $ (7,137,375)  
Adjustments to reconcile net loss to net cash used in operating activities:              
Amortization of original issue discount         93,458 699,354  
Depreciation and amortization expense 1,050,440   1,674   2,094,026 2,232  
Amortization of right of use asset         27,616  
Realized loss on equity investment         (54,760)  
Change in fair value of convertible notes payable 27,608     287,460  
Gain on extinguishment of liabilities (343,366)   0   (412,286) (18,301)  
Equity-based compensation 167,631   190,359   327,214 190,359  
Inventory write-downs         43,712 0  
Allowance for doubtful accounts         199,000  
Changes in operating assets and liabilities              
Accounts receivable         28,801  
Inventories         2,883 27,954  
Prepaid expenses and other         (57,902) (270,985)  
Interest receivable         (3,925) (41,293)  
Accounts payable         121,600 2,115,073  
Accrued compensation         516,968 337,690  
Accrued creator commissions         57,911 25,195  
Settlement payable         (93,289) 156,405  
Accrued expenses         (193,243) (300,312)  
Accrued sales tax         32,927 (32,382)  
Deferred revenue         (172,861) 370,064  
Operating lease         (15,812)  
Net cash used in operating activities         (7,176,257) (3,902,281)  
Cash flows from investing activities              
Cash acquired through acquisition (Note 2)         591,686  
Capitalized internally developed software         (271,427)  
Intangible asset acquired in Kast acquisition         (210,430)  
Issuance of note receivable         (900,000)  
Net cash used in investing activities         (481,857) (308,314)  
Cash flows from financing activities              
Proceeds from debt, net of issuance costs         2,488,241  
Proceeds from financing arrangement, net of issuance costs         714,754  
Proceeds from convertible notes payable and warrants         264,881  
Repayment of debt         (1,015,189) (363,365)  
Deferred offering costs         5,925  
Warrants issued in conjunction with debt         213,553  
Issuance of common stock in conjunction with securities purchase agreement         262,500  
Issuance of common stock from Equity Line of Credit, net of issuance costs         1,319,513  
Issuance of common stock from At-The-Market Offering, net of issuance costs         6,849,817  
Proceeds from issuance of Series C preferred stock – net of issuance costs         785,067  
Net cash provided by financing activities         7,160,066 4,365,631  
Net increase (decrease) in cash         (498,048) 155,036  
Cash - beginning of period   $ 2,874,710   $ 155,647 2,874,710 155,647 $ 155,647
Cash - end of period $ 2,376,662   $ 310,683   2,376,662 310,683 $ 2,874,710
Supplemental disclosure of non-cash investing and financing activities              
Series A preferred dividends converted to common stock         223,167  
Right of use asset obtained in exchange for operating lease         153,875  
Convertible notes converted to common stock         654,333  
Acquisition through issuance of Series D and Merger Warrants         75,000,000  
Repayment of debt with investment         521,260  
Forgiveness of note receivable and interest with note payable and interest from Acquisition         4,478,181  
Issuance cost in conjunction with name change         56,667  
Accrued Series A dividends         $ 18,600 $ 109,533